10 Best Gene Editing Stocks To Buy
A report by The Wall Street Journal dated September 16 suggests that Intellia Therapeutics, Inc.
Beam Therapeutics Inc. (BEAM)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Cathie Wood Dumped These 7 Stocks in July
In June, Cathie Wood’s ARK Investment Management suffered a sharp decline in assets, which was decidedly higher than most US exchange traded funds in 2022.
Cathie Wood's 2022 Portfolio: 5 Small-Cap Stock Picks
In this article, we discuss the 5 small-cap stock picks of Cathie Wood's 2022 portfolio.
10 Genomics Stocks in Cathie Wood's Portfolio That Are Underperforming
In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming.
Top 10 Biotech Stocks to Buy According to Jeremy Green's Redmile Group
In this article, we will discuss the top 10 biotech stocks to buy according to Jeremy Green's Redmile Group.
10 Biotech Stocks To Buy According To Chinese Billionaire Lei Zhang
In this article, we discuss 10 biotech stocks to buy according to Chinese billionaire Lei Zhang.
10 Best Genomics Stocks to Buy Now
Genomics is the branch of biology that deals with the study of human genes. The genome is the complete set of DNA of an organism. Every cell carries copies of nearly three billion DNA base pairs.
10 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital
In this article, we reviewed Jim Simons' investment strategy, historical performance, and family office portfolio.
Hedge Funds Are Warming Up To Beam Therapeutics Inc. (BEAM)
In this article we will analyze whether Beam Therapeutics Inc.
11 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital
In this article, we will discuss the 11 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
